PTJ
ANVS icon

Paul Tudor Jones’s Annovis Bio ANVS Stock Holding History

Paul Tudor Jones’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
+1,357,134
New +$2.64M ﹤0.01% 1778

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Paul Tudor Jones's ANVS Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Annovis Bio (ANVS) in Q2 2026: 1,357,134 shares worth $2.52M. The stake represents ﹤0.01% of the portfolio and ranks #1778 among its holdings.

61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Paul Tudor Jones held 1,357,134 shares of Annovis Bio worth $2.52M as of Q2 2026.
  • Annovis Bio was a new Paul Tudor Jones position in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1778 holding.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.